US Patent Issued to Levron Cardiovascular on July 8 for "Treatment of cardiac decompensation, pulmonary congestion and dyspnea" (Israeli Inventor)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,498, issued on July 8, was assigned to Levron Cardiovascular Ltd. (Yokneam Ilit, Israel).

"Treatment of cardiac decompensation, pulmonary congestion and dyspnea" was invented by Amir Landesberg (Haifa, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for treatment of cardiac problems includes performing modulation of a cardiac rhythm of a patient by increasing a number of heart beats the patient during time interval with high pleural pressure relative to the number during low (negative) pleural pressure, wherein an amplitude of the modulation of the cardiac rhythm between these segments is determined by severity of a respiratory effort ...